Campuses

As France's leading biocluster, Genopole is an incubator for cutting-edge projects in biotechnology. Located in the city of Évry, just south of Paris, Genopole provides a unique environment for scientists and entrepreneurs seeking to advance research and innovation.

Discover >

Advantages

Genopole accompanies researchers, postdocs and start-up entrepreneurs through all the phases of their projects to ensure the best possible conditions for business development.

Discover >

Genopole’s citizens

Every day, at Genopole, researchers, entrepreneurs and students cross paths, share ideas and unite forces in a veritable melting pot for innovation.

Discover >

Highlights

Giving wings to research and empowering employment in our community are cornerstones of Genopole's mission. Catch up on recent scientific advances, the accomplishments of our biotech actors and the events that enliven the biocluster.

Discover >

Innovate with us

Discover >
Company

XenTech


Pépinière Genopole Entreprises – 4, rue Pierre Fontaine – Genopole Campus 3
91058 EVRY Cedex – FRANCE
Phone: +33 1 60 87 89 80
Email: contact@xentech.eu

Jean-Gabriel JUDDE: President & CSO
Site Web >
Xentech - Genopole Company Xentech - Genopole Company

#R&D Services and Products

  • Oncology
  • Preclinical expertise
  • Predictive models
  • Biomarkers
  • Companion tests
  • New therapeutic targets
  • Patient-derived tumor xenografts

Field of Activity


XenTech is an innovative biotech company specialized in the preclinical evaluation of cancer drugs and the identification of biomarkers and therapeutic targets.

BACKGROUND

XenTech was founded in 2006 by researchers from the Institut Curie having over 15 years of experience in preclinical pharmacology in oncology. This spin-off company dedicated to biomarker discovery and preclinical evaluation of anticancer therapies is known worldwide for its expertise in the field of patient-derived tumor xenografts (PDX).
Located on the Genopole Campus, its experimental models are housed at the CERFE.

DESCRIPTION OF THE PRODUCTS / SERVICES / TECHNOLOGY

XenTech develops an innovative experimental platform based on one of the world’s largest collections of patient derived tumors xenografts (PDX). The collection is representative of the major types of cancer (breast, lung, colon, prostate) but also includes less common tumors (melanoma, ovarian cancer, renal cancer, pancreatic cancer, glioma, hepatoblastoma).
XenTech’s platform is of considerable value for translational research in oncology, notably for drug screening and the identification of biomarkers useful for precision oncology.
XenTech participates in the development of novel cancer therapies by offering its services, models and expertise in preclinical oncology to stakeholders in oncology research.

CUSTOMER REFERENCES / COLLABORATIONS / HIGHLIGHTS

  • Partnership with the world’s biggest pharmaceutical companies involved in oncology.
  • Partnerships with major Cancer Centers.
  • Member of the ITCC-P4 consortium, a European IMI2 project to develop a platform for pediatric cancer models

COLLABORATIONS SOUGHT

  • Collaborative partnership with the pharmaceutical industry on drug response biomarkers and new therapeutic targets discovery programs.
  • Collaborative partnership with hospital structures to pursue development of the preclinical platform.
  • Research fee-for-service contracts with pharmaceutical companies, biotechs and academic groups for evaluating antitumor efficacy of their drug candidates.
  • Further Information

    Annual turnover: €3M
    32 staff members

    STRENGTHS:
    A unique panel of breast cancers preclinical models.
    World-renowned experimental platform and scientific expertise.

    INNOVATION ASSETS:
    An experimental platform and scientific expertise recognized worldwide.
    A network of partners and customers extended internationally.

Share
Genopole’s Companies

#R&D Services and Products


In same field

Quibiotic - Projet Shaker

Quibiotic

Quibiotic develops three molecular synthesis platforms aimed at innovatively modifying β-lactam rings for new anti-infectives.

Discover
Adlin Science - Genopole's Company

Adlin Science

ADLIN Science accompanies researchers in the management, analysis and valorization of multiomic data

Discover
Altar - entreprise génopolitaine

Altar

Altar is a specialist in the conception and operation of automated fluidic continuous culture systems for adaptive laboratory evolution and the development of microbial strains for industry.

Discover
Yubsis - Genopole's company

Yubsis

Yubsis provides Biological Science Information Solutions. Our platform is designed for research organizations (Pharma, Biotech, academic lab) willing to improve real-time teamwork, optimize performance and accelerate innovation.

Discover
Whitelab Genomics - Genopole's Company

WhiteLab Genomics

Artificial intelligence to optimize and accelerate the development of gene therapies

Discover
Pymabs - Genopole's Company

Pymabs

R & D services in the field of transient expression of recombinant proteins in plants.

Discover
Polytheragene - Genopole's Company

Polytheragene

Manufacture and sale of new high performance transfecting agents for gene therapy, high-throughput screening and biomanufacturing. Cosmetic and therapeutic molecules from plant biomass.

Discover
Phinc Development - Genopole's Company

PhinC Development

PhinC Development brings its expertise to small and mid-sized biotechs and pharmaceutical companies looking to advance their early-stage drug research.

Discover
New England Biolabs - Genopole's Company

New England Biolabs France

New England Biolabs is a private company manufacturing reagents for the life science industry particularly focused on products for genomic research.

Discover
LPS Biosciences - Genopole's company

LPS-BioSciences

LPS-BioSciences is specialized in bacterial endotoxins. It combines an exclusive proprietary technology for endotoxin production and characterization. and its acquired experience in the fields of vaccines, diagnostics, and the food industry.

Discover
Hybrigenics - Genopole's company

Hybrigenics Services

Hybrigenics Services proposes fee-for-services R&D support and provides innovative technological platforms for i) protein interaction studies (protein-protein, drug-protein, mechanisms of action) and ii) selection and validation of VHH antibodies.

Discover
logo abcell Bio - Genopole's Companie

ABCell-Bio

Abcell-bio is a laboratory specializing in the isolation of human hematopoietic stem cells and primary cells derived from perinatal tissue and cord blood.

Discover
View all >
With the support from